Home

All Clinical Trials

Texas

Amarillo

Amarillo, TX Clinical Trials

A listing of Amarillo, TX clinical trials actively recruiting patient volunteers.

Show Filters

Match to Clinical Trials

Access to cutting-edge treatments

Latest clinical trials

Find trials in your area

Start Matching

Search by Name

Filter by Condition

Filter by Age

Filter by Type

Search by Name

Filter by Condition

89 trials found

Featured Trials

A Vaccine Trial For Healthy Women Between 16-40

Recruiting

A Cytomegalovirus (CMV) Investigational Vaccine Clinical Trial for Healthy Women Age 16 to 40. Compensation included.

Conditions: Healthy Volunteers

Learn More

Featured Trials

A Vaccine Trial for People Who Have Recieved a Transplant

Recruiting

A COVID-19 vaccine study for people who have received kidney or liver transplants. Compensation included.

Conditions: Healthy Volunteers

Learn More

Featured Trials

Alzheimer's Disease Study

Recruiting

New research opportunity for people with mild cognitive impairment or early stage Alzheimer's.

Male & Female, 50-80 Years Old

Conditions: Alzheimers, Dementia

Learn More

Featured Trials

Parkinson's Research Opportunity

Recruiting

Take your place in a new project exploring the genetics of Parkinson’s. Join our Parkinson’s research for the chance to receive a free genetic test.

Conditions: Parkinson's Disease

Learn More

Featured Trials

Ulcerative Colitis Study Research Opportunity

Recruiting

A new ulcerative colitis research study with Sano Genetics allows you to take part in world-leading research entirely from home

Conditions: Ulcerative Colitis, IBD, Crohn's Disease

Learn More

Featured Trials

A COVID-19 Vaccine Study For Teenagers

Recruiting

An investigational COVID-19 vaccine study for adolescents

Conditions: Healthy Volunteers

Learn More

Featured Trials

A Vaccine Trial for Adults 60+

Recruiting

A Study to Evaluate the Safety and Efficacy of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥60 Years of Age

Conditions: Healthy Volunteers

Learn More

Featured Trials

A mRNA Vaccine Trial for Adults

Recruiting

A clinical trial evaluating investigational mRNA vaccines in adults

Conditions: Healthy Volunteers

Learn More

Featured Trials

A COVID-19 Vaccine Study for Children

Recruiting

A COVID-19 Vaccine Study for Children

Conditions: Healthy Volunteers

Learn More

Featured Trials

A Vaccine Study for Children

Recruiting

A Dose Escalation Study to Evaluate Safety, Reactogenicity, and Immunogenicity of mRNA-1345

Conditions: Healthy Volunteers

Learn More

Featured Trials

A Hodgkin Lymphoma (HL) Clinical Trial

Recruiting

A Study of Brentuximab Vedotin With Hodgkin Lymphoma (HL) and CD30-expressing Peripheral T-cell Lymphoma (PTCL)

Conditions: Hodgkin Lymphoma, Peripheral T Cell Lymphoma

Learn More

Featured Trials

A Urothelial/Bladder Cancer Clinical Trial

Recruiting

A Study of Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial Cancer

Conditions: Bladder Cancer, Carcinoma, Transitional Cell, Urinary Bladder Neoplasms, Urologic Neoplasms, Renal Pelvis Neoplasms, Urothelial Cancer, Ureteral Neoplasms, Urethral Neoplasms

Learn More

Featured Trials

A Myelofibrosis Treatment Clinical Trial

Recruiting

To Evaluate Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis Who Have Suboptimal Response to Ruxolitinib (LIMBER-304)

Conditions: Myelofibrosis, Primary Myelofibrosis, Post Essential Thrombocythemia Myelofibrosis, Post Polycythemia Vera Myelofibrosis

Learn More

Featured Trials

A Melanoma Treatment Clinical Trials

Recruiting

A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

Conditions: Melanoma, Solid Tumor, NSCLC

Learn More

Featured Trials

A Peripheral T Cell Lymphoma Clinical Trials

Recruiting

Assessing An Oral Janus Kinase Inhibitor, AZD4205 as Monotherapy in Patients Who Have PTCL (JACKPOT8)

Conditions: Peripheral T Cell Lymphoma (PTCL), Relapsed or Refractory

Learn More

Featured Trials

A Melanoma Treatment Clinical Trials

Recruiting

CMP-001 in Combination With Nivolumab Compared to Nivolumab Monotherapy in Subjects With Advanced Melanoma

Conditions: Melanoma, Advanced Melanoma, Metastatic Melanoma, Unresectable Melanoma

Learn More

Featured Trials

A Hodgkin Lymphoma (HL) + Peripheral T Cell Lymphoma Clinical Trial

Recruiting

A Study of Retreatment With Brentuximab Vedotin in Subjects With Classic Hodgkin Lymphoma or CD30-expressing Peripheral T Cell Lymphoma

Conditions: Hodgkin Lymphoma, Peripheral T Cell Lymphoma, Anaplastic Large Cell Lymphoma

Learn More

Featured Trials

A Diffuse Large B-Cell Lymphoma (DLBCL) Clinical Trial

Recruiting

Brentuximab Vedotin Plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCL

Conditions: Diffuse Large B-cell Lymphoma (DLBCL)

Learn More

Featured Trials

Meningitis Vaccine Clinical Studies for Ages 16-18

Recruiting

Help protect yourself and other teens and kids against meningitis by joining a clinical study!

Conditions: Healthy Volunteers

Learn More

Featured Trials

Meningitis Vaccine Clinical Studies for Ages 11-14

Recruiting

The purpose of this clinical study is to evaluate two different dosing schedules for an investigational meningococcal vaccine in preventing a meningitis infection in children, which is a serious and potentially life-threatening bacterial infection of the brain.

Conditions: Healthy Volunteers

Learn More

Featured Trials

Enlarged Prostate Clinical Trial for Men

Recruiting

Enlarged Prostate Clinical Trial for Men

Conditions: Healthy Volunteers

Learn More

Featured Trials

Hepatitis B Clinical Studies

Recruiting

Hepatitis B Clinical Studies

Conditions: Hepatitis B

Learn More

Featured Trials

Asthma Clinical Studies

Recruiting

Asthma Clinical Studies

Conditions: Asthma

Learn More

Featured Trials

Clinical Studies for COPD

Recruiting

Clinical Studies for COPD

Conditions: COPD

Learn More

Featured Trials

Ulcerative Colitis Clinical Trials

Recruiting

Ulcerative Colitis Clinical Trials

Conditions: Ulcerative Colitis

Learn More

Featured Trials

Crohn's Disease Clinical Studies

Recruiting

Crohn's Disease Clinical Studies

Conditions: Crohn's Disease

Learn More

Featured Trials

Diabetic Nerve Pain Study

Recruiting

Diabetic Nerve Pain Study

Conditions: Type I Diabetes, Type II Diabetes, Neuropathic Pain, Diabetic Neuropathy

Learn More

Featured Trials

Fatty Liver/Nash Clinical Trials

Recruiting

Fatty Liver/Nash Clinical Trials

Conditions: Cirrhosis, Fatty Liver Disease, Non-Alcoholic Steatohepatitis (NASH)

Learn More

Featured Trials

Parkinson's Disease of Lewy Body Dimentia Clinical Trials

Recruiting

Parkinson's Disease of Lewy Body Dimentia Clinical Trials

Conditions: Lewy Body Dementia (LBD), Parkinson's Disease

Learn More

Featured Trials

Clinical Study for People at Risk of Developing Alzheimer's Disease

Recruiting

Clinical Studies for People at Risk of Developing Alzheimer's Disease

Conditions: Alzheimers, Dementia

Learn More

Featured Trials

Glaucoma Treatment Clinical Studies

Recruiting

The purpose of these clinical studies are to test the efficacy of treatments in reducing high eye pressure. You may qualify to participate if you have been diagnosed with open-angle glaucoma or ocular hypertension in one or both of your eyes.

Conditions: Glaucoma, Ocular Hypertension

Learn More

A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Semaglutide (COMBINE 2)

NCT05259033

This study will compare the new medicine IcoSema, which is a combination of insulin icodec and semaglutide, taken once a week, to semaglutide taken once a week in people with type 2 diabetes. The study will look at how well IcoSema controls blood sugar level in people with type 2 diabetes compared to semaglutide. Participants will either get IcoSema or semaglutide. Which treatment participants get is decided by chance. IcoSema is a new medicine that doctors cannot prescribe. Doctors can alread ...

Conditions: Diabetes Mellitus, Type 2

Phase: Phase 3

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab Monotherapy in Participants With Select B-Cell Malignancies

NCT05207670

This study will evaluate the efficacy, safety, and pharmacokinetics of mosunetuzumab subcutaneous (SC) formulation in participants with selected B-cell malignancies (types of non-Hodgkin's lymphoma [NHL]).

Conditions: Non-Hodgkin Lymphoma

Phase: Phase 2

Efficacy and Safety of Tozorakimab (MEDI3506) in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations.

NCT05158387

The purpose of this Phase III study is to evaluate the efficacy and safety of Tozorakimab (MEDI3506) Dose 1 and Dose 2 administered subcutaneously (SC) in adult participants with symptomatic COPD and history of ≥ 2 moderate or ≥ 1 severe exacerbation of COPD in the previous 12 months. Participants should be receiving optimised treatment with maintenance inhaled therapy (ICS/LABA/LAMA triple therapy, or dual therapy if triple is not indicated or contraindicated) at a stable dose for at least 3 mo ...

Conditions: Chronic Obstructive Pulmonary Disease (COPD)

Phase: Phase 3

PATHFINDER 2: A Multi-Cancer Early Detection Study

NCT05155605

This is a prospective, multi-center interventional study of the GRAIL multi-cancer early detection (MCED) test with return of test results for participants enrolled through healthcare systems in North America. The purpose of this study is to evaluate the safety and performance of the GRAIL MCED test in a population of individuals who are eligible for guideline-recommended cancer screening. In cases with a "cancer signal detected" test result, participants will undergo diagnostic procedures based ...

Conditions: Early Detection of Cancer, Cancer

Phase: Not Applicable

A Study of ZN-c3 in Subjects With Malignant Tumors

NCT05128825

This is a Phase 2 open-label, multicenter study to evaluate the clinical activity, safety, pharmacokinetics (PK), and biomarker profile of ZN-c3 in subjects with locally advanced or metastatic solid tumor malignancies harboring biomarkers related to deoxyribonucleic acid (DNA) damage pathways

Conditions: Solid Tumor

Phase: Phase 2

Zilebesiran as Add-on Therapy in Patients With Hypertension Not Adequately Controlled by a Standard of Care Antihypertensive Medication (KARDIA-2)

NCT05103332

The purpose of this study is to evaluate the effect of zilebesiran on systolic and diastolic blood pressure and to characterize the pharmacodynamic (PD) effects and safety of zilebesiran as add-on therapy.

Conditions: Hypertension

Phase: Phase 2

A Study to Evaluate the Efficacy and Safety of Intravitreal KSI-301 in Participants With Moderately Severe to Severe Non-proliferative Diabetic Retinopathy (NPDR)

NCT05066230

This Phase 3 Study will evaluate the efficacy and safety of KSI-301 in participants with moderately severe to severe non-proliferative diabetic retinopathy (NPDR).

Conditions: Non-proliferative Diabetic Retinopathy

Phase: Phase 3

A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection

NCT05047601

The purpose of this clinical trial is to learn whether the study medicine prevent symptoms of COVID-19 in adults who have been exposed to household member(s) with a confirmed symptomatic COVID-19 infection. All participants in the study will receive treatment for COVID-19 as needed, based on their regular doctor's recommendation. Two-thirds of participants will also receive two study medicines (PF-07321332 and ritonavir) by mouth twice a day for either five or ten days. We will compare the expe ...

Conditions: COVID-19

Phase: Phase 3

Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease

NCT05030428

Study CKJX839B12302 is a pivotal Phase III trial to evaluate the benefits of inclisiran on major adverse cardiovascular (MACE) events in participants with established cardiovascular disease (CVD).

Conditions: Atherosclerotic Cardiovascular Disease

Phase: Phase 3

A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Insulin Glargine Taken Daily With Insulin Aspart (COMBINE 3)

NCT05013229

This study will compare the new medicine IcoSema, which is a combination of insulin icodec and semaglutide, taken once a week, to insulin glargine taken daily with insulin aspart in people with type 2 diabetes.The study will look at how well IcoSema controls blood sugar level in people with type 2 diabetes compared to insulin glargine taken with insulin aspart. Participants will either get IcoSema or insulin glargine taken with insulin aspart. Which treatment participants get is decided by chanc ...

Conditions: Diabetes Mellitus, Type 2

Phase: Phase 3

Evaluation of Protease Inhibition for COVID-19 in Standard-Risk Patients (EPIC-SR).

NCT05011513

The primary hypothesis to be tested is whether or not there is a difference in time to sustained alleviation of all targeted COVID-19 signs and symptoms through Day 28 between PF-07321332/ritonavir and placebo.

Conditions: COVID-19

Phase: Phase 2/3

realMIND: Observational Study of Patients With Relapsed or Refractory DLBCL Starting Second- or Third-line Therapy

NCT04981795

REAL-MIND: Prospective multicenter observational study of patients with relapsed or refractory diffuse large B-cell lymphoma starting second- or third-line therapy and not receiving autologous stem cell transplant

Conditions: Diffuse Large B-cell Lymphoma

Phase: N/A

Show Filters

Match to Clinical Trials

Access to cutting-edge treatments

Latest clinical trials

Find trials in your area

Start Matching

Search by Name

Filter by Condition

Filter by Age

Filter by Type

All updated clinical trials provided by:

Medical Disclaimer

This content is for informational and educational purposes only. It is not intended to provide medical advice or to take the place of such advice or treatment from a personal physician. All readers/viewers of this content are advised to consult their doctors or qualified health professionals regarding specific health questions. Policylab.us does not take responsibility for possible health consequences of any person or persons reading or following the information in this educational content. All viewers of this content, especially those taking prescription or over-the-counter medications, should consult their physicians before beginning any nutrition, supplement or lifestyle program